Navigation Links
S1P1 Lead Compounds, Assets Generated by Epix Pharmaceuticals, Inc. and Amgen, Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Target Rationale for S1P1 Agonists Explained.
Date:11/8/2011

WELLESLEY HILLS, Mass., Nov. 8, 2011 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc. ("Epix") announced today that the S1P1 lead compounds, assets generated by Epix Pharmaceuticals, Inc. and Amgen, will be offered December 8, 2011 in a sealed bid sale.  Target rationale for S1P1 agonists explained.

The sphingosine-1-phosphate receptor 1 (S1P1) is one of a family of five G-protein-coupled receptors and is expressed ubiquitously.  Its ligand, sphingosine-1-phosphate (S1P) is present at high levels in the blood and lymph but at much lower levels in secondary lymph organs: movement in response to this gradient is believed to be a critical factor in the egress of activated lymphocytes from the lymph node and spleen.  Therefore, the receptor has received considerable attention as a potentially important target for therapeutic intervention.  Seminal studies with fingolimod have provided much of the validation of S1P1 as a therapeutic target in autoimmunity and inflammation.  

Assets included in the sale include preclinical and toxicology data related to AMG 277, AMG 369 and six backup compounds, existing inventory of these compounds (API), and related patent portfolio.

Persons interested in bidding must sign a Confidentiality Disclosure Agreement ("CDA") obtained from Finn's office – jffinnjr@finnwarnkegayton.com or 781-237-8840; upon receipt of the executed CDA, applicants will receive a bid package, to be completed and returned by December 8, 2011.

About Joseph F. Finn, Jr., C.P.A.

Joseph F. Finn, Jr., C.P.A. is the founding partner of the firm, Finn, Warnke & Gayton, Certified Public Accountants of Wellesley Hills, Massachusetts.  He works primarily in the area of management consulting for distressed enterprises, bankruptcy accounting and related matters, such as assignee
'/>"/>

SOURCE Joseph F. Finn, Jr., C.P.A.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. S1P1 Lead Compounds, AMG 369 and AMG 277, Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale
2. Contractual Agreements Revealed for S1P1 Lead Compounds, AMG 369 and AMG 277, Offered for Sale at a December 8, 2011 Sealed Bid Sale
3. Back-Up Compounds and S1P1 Lead Compounds, Assets Generated by Epix Pharmaceuticals, Inc. and Amgen, Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale
4. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
5. Sosei Assigns AD 923 Assets to Pharmasol
6. Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medicals Subsidiary, Sanvita, Inc.
7. Nyer Medical Group, Inc., Announces Agreements to Sell Certain Eaton Apothecary Assets to Walgreens and Sell Operating Subsidiarys Stock to Investors
8. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
9. Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75
10. Wound Management Technologies Completes Acquisition of Secure eHealth, LLC and Other Assets from VirtualHealth Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
11. VirtualHealth Technologies Completes Sale of Secure eHealth, LLC and Other Assets to Wound Management Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015  Acsis Inc., the market leader for supply ... that John DiPalo , Acsis, Chief Strategy Officer, ... Chain Executive 2015 Provider Pro to Know. The ... to help prepare their companies, and customers, supply chains ... year,s list of Provider Pros to Know is featured ...
(Date:2/27/2015)... 2015 - ... di monitoraggio dell,infarto congestizio (CHF - Congestive Heart ...     Vectorious Medical Technologies, ... per il monitoraggio cardiaco destinato a pazienti affetti ... aver concluso una raccolta di finanziamenti per 5 ...
(Date:2/27/2015)... Pharmaceuticals, Inc. (Nasdaq: ISIS ) today announced ... loss (NOL) guidance and its cash guidance ending the ... financial results were due in large part to the ... from its partners.  Isis, pro forma NOL of $16.3 ... its 2013 NOL of $40.2 million. On a GAAP ...
Breaking Medicine Technology:Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17
... Feb. 9, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... company, announced today that the United States District ... ruled that Watson,s generic versions of Mucinex®, Mucinex® ... and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. ...
... England Biolabs (NEB) has published a video protocol ... the EpiMark™ 5-mC and 5-hmC Analysis Kit, one ... designed to simplify DNA methylation analysis for epigenetics ... to identify and quantitate 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine ...
Cached Medicine Technology:Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit 2New England Biolabs Releases JoVE Video Protocol Highlighting Assay to Quantitate 5-hmC in Epigenome 2
(Date:2/27/2015)... February 27, 2015 Pipette.com announces their ... , price is only valid until the end of ... looking for a vortex mixer that allows for absolute ... founded in 1954 and is headquartered in Bohemia, New ... shakers, as well as other rockers, incubators, and hybridization ...
(Date:2/27/2015)... 27, 2015 In New York City, ... by providing free dental care from his Sheepshead Bay­neighborhood ... with Dentistry from the Heart, and will be hosting ... first 50 patients who are in need of fillings, ... will have access to high­quality service of Dr. Umanoff's ...
(Date:2/27/2015)... The V Foundation for Cancer Research, ... is excited to announce numerous promotions taking place this ... long-standing partnerships highlight The V Foundation’s significant work in ... for all to get involved. Awarding 100 percent ... The V Foundation has funded more than $130 million ...
(Date:2/27/2015)... February 27, 2015 Royal River Natural Foods, ... a new study that found adults who got the most ... 2 diabetes compared to those who got the least magnesium, ... levels. , The report is part of the March 2015 ... Royal River Natural Foods publishes free each month for the ...
(Date:2/27/2015)... IL (PRWEB) February 27, 2015 According ... Lutheran General Hospital on June 25, 2013 and underwent ... her stomach through her mouth. Because the duodenoscope ... infected with the antibiotic-resistant “superbug” carbapenem-resistant Enterobacteriaceae (CRE). ... Circuit Court of Cook County on behalf of Ms. ...
Breaking Medicine News(10 mins):Health News:Pipette.com Announces Limited Time Offer of 24% Off List Price on the Vortex-Genie 2 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 2Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 3Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2
... ... products, offers a compelling "first step" for couples experiencing difficulty in conceiving. , ... Bellingham, WA (Vocus) July ... related products, offers a compelling "first step" for couples experiencing difficulty in conceiving. ...
... been seeking a one-stop resource for pharmaceutical marketing information, ... launched to provide pharmaceutical marketing professionals with conference-quality resources ... The site offers users access to world class ... articles and best practices from thought leaders and up-to-the-minute ...
... Families USA, between 2007 and 2008, nearly one out of ... without health insurance. In an effort to bring awareness ... 2009, Teva Pharmaceuticals USA, the leading generic pharmaceutical company, is ... Illinois. The event will be the second in a series ...
... drug prices are stinging Illinoisans over the age 50 -- forcing ... and utilities, in order to afford needed medications. According to ... increases, the majority of the state,s 50 plus population are worried ... year. , , "No one should have to ...
... can improve the health of high-risk patients by reviewing ... plan recommendations with primary care physicians, according to a ... Medical Journal. , , The quality ... take a more active role in managing the health ...
... HealthCare Pharmaceuticals launched the BayCuff(TM) self-infusion training program, an ... VIII easier for both patients with hemophilia A and ... is an adjustable cuff worn on the hand or ... self-injection without actually infusing themselves and helps caregivers learn ...
Cached Medicine News:Health News:The Path to Pregnancy: Fairhaven Health Offers New Natural Products to Help Couples Conceive 2Health News:The Path to Pregnancy: Fairhaven Health Offers New Natural Products to Help Couples Conceive 3Health News:The Path to Pregnancy: Fairhaven Health Offers New Natural Products to Help Couples Conceive 4Health News:The Path to Pregnancy: Fairhaven Health Offers New Natural Products to Help Couples Conceive 5Health News:Pharma-Marketer.com: One-Stop Pharmaceutical Marketing Resource 2Health News:Businesses, Community Leaders Invited to Come Together to Examine the Rising Cost of Healthcare 2Health News:High Rx Costs Hammering Illinois' 50+ Population 2Health News:Kaiser Permanente Project Proves Electronic Health Information and Care Coordination Improve Chronic Disease Management 2Health News:Kaiser Permanente Project Proves Electronic Health Information and Care Coordination Improve Chronic Disease Management 3Health News:Kaiser Permanente Project Proves Electronic Health Information and Care Coordination Improve Chronic Disease Management 4Health News:Bayer HealthCare Launches Hemophilia Self-Infusion Training Program 2Health News:Bayer HealthCare Launches Hemophilia Self-Infusion Training Program 3Health News:Bayer HealthCare Launches Hemophilia Self-Infusion Training Program 4Health News:Bayer HealthCare Launches Hemophilia Self-Infusion Training Program 5
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: